XNCR Q2 2018 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$23M

Operating Income

-$28M

Net Income

-$26M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$30M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$591M

Total Liabilities

$72M

Stockholders' Equity

$519M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$13M	-100.0%
Gross Profit	-$23M	-$4M	-551.9%
Operating Income	-$28M	-$8M	-268.8%
Net Income	-$26M	-$7M	-275.7%